Synthokem Labs

What Synthokem Labs does

Synthokem Labs Private Limited is an Indian manufacturer of Active Pharmaceutical Ingredients (APIs) and drug intermediates, headquartered in Hyderabad, Telangana. The company operates three integrated manufacturing facilities — Unit-I at Visakhapatnam (Andhra Pradesh), Unit-II at Pashamylaram (Telangana, operational since 2010), and a corporate office in Hyderabad — with a workforce of over 300 people. Founded in 1978, Synthokem's product portfolio comprises 13 distinct APIs across diverse therapeutic categories (expectorants such as Guaifenesin, muscle relaxants such as Methocarbamol and Mephenesin, antifungals, anti-spasmodics, anti-hypertensives, gastrointestinal medications, and dietary supplements), plus the Silica Thiol intermediate, and contract manufacturing services for third-party APIs and intermediates.

Synthokem's core technology is conventional chemical synthesis at production scale, with capabilities in advanced process chemistry — including Chloromethylation, Halogenations, Hydrogenations, High Vacuum Distillations, Racemisation, Williamson Synthesis, Friedel-Crafts Acylation, Esterification, Aldol Reaction, Radical Bromination, and Drazens Reaction — supported by backward integration into intermediates and state-of-the-art analytical facilities. The company scales from gram-level to multi-ton supply, complying with Ph. Eur, USP, BP, JP, and IP pharmacopoeia standards. Quality systems cover Quality Control, Quality Assurance, and Quality Commitment.

The business model is B2B enterprise sales to global generic and innovator pharmaceutical companies across 40+ countries, with quote-based pricing (not publicly disclosed). The company has Drug Master Files on record with USFDA (since 1993), Health Canada, BfArm-Germany, MHRA-UK, AFSSAPS-France, and Ireland. Revenue is generated through direct sale of proprietary APIs and intermediates, plus contract manufacturing services. The company is privately held and founder/management-owned, with Jayant Tagore Madireddy as Chairperson. No external institutional investors, funding rounds, or M&A activity since the 2004 Pashamylaram site acquisition are disclosed.

Name

Synthokem Labs

Legal name

Synthokem Labs Private Limited

Website

https://synthokemlabs.com

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

251–500 employees

Short description

Synthokem Labs is a Hyderabad-based, privately held Indian manufacturer of Active Pharmaceutical Ingredients (APIs) and drug intermediates, operating three manufacturing facilities and supplying generic and innovator pharmaceutical companies across 40+ countries since 1978.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Custom Intermediates & Advanced Intermediates Manufacturing (HLAGAHAH), Generic APIs & Intermediates (Active Ingredients) (HLAIABAG), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Small-Molecule API Process Development & Route Scouting (HLAGAHAA)

Keywords

• Active pharmaceutical ingredients
• Drug intermediates manufacturing
• Pharmaceutical contract manufacturing
• API manufacturing
• Chemical synthesis services

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Active Pharmaceutical Ingredients (APIs): Manufacturing and sale of Active Pharmaceutical Ingredients across diverse therapeutic areas including expectorants, muscle relaxants, anti-fungal, anti-spasmodic, anti-hypertensive, gastrointestinal, and dietary supplements. Products include Guaifenesin, Mephenesin, Chlorphenesin, Methocarbamol, Potassium Guaiacol Sulfonate, Chlorphenesin Carbamate, Drotaverine Hydrochloride, Mebeverine Hydrochloride, Terazosin Hydrochloride, Prazosin Hydrochloride, Calcium polycarbophil, and Calcium Glycerophosphate.
2. Drug Intermediates: Manufacturing and supply of pharmaceutical intermediates for the global pharmaceutical market. Focus on producing cutting-edge intermediates for new as well as off-patent APIs within requisite time frames.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

Synthokem Labs manufactures and supplies Active Pharmaceutical Ingredients (APIs) and drug intermediates for the global pharmaceutical industry. The company produces a focused portfolio of 13 APIs across therapeutic categories including expectorants, muscle relaxants, antifungals, anti-spasmodics, anti-hypertensives, gastrointestinal medications, and dietary supplements, plus intermediates like Silica Thiol, in multiple pharmacopoeia grades (USP, EP, BP, JP, IP, BPC). It also offers contract manufacturing services across three integrated manufacturing facilities in India.

Product overview

Synthokem Labs is a manufacturer of Active Pharmaceutical Ingredients (APIs) and drug intermediates, headquartered in Hyderabad, India. The company offers a focused portfolio of 13 distinct APIs across diverse therapeutic categories (expectorants, muscle relaxants, antifungals, anti-spasmodics, anti-hypertensives, gastrointestinal medications, and dietary supplements) plus one intermediate product (Silica Thiol). The company also provides contract manufacturing services for APIs and intermediates through three integrated manufacturing facilities equipped with advanced machinery and technologies. The product portfolio spans multiple pharmacopoeia grades including USP, EP, BP, JP, IP, and BPC, enabling global regulatory compliance.

Differentiator

Problem solved

Functional benefit

Products and services

• Guaifenesin An expectorant Active Pharmaceutical Ingredient used for respiratory conditions, available in USP/EP/BP/JP/IP pharmacopoeia grades for global pharmaceutical manufacturers.
• Mephenesin A skeletal muscle relaxant Active Pharmaceutical Ingredient available in BPC/IP/IH pharmacopoeia grades.
• Chlorphenesin An antifungal Active Pharmaceutical Ingredient available in BP/IP pharmacopoeia grades.
• Methocarbamol A skeletal muscle relaxant Active Pharmaceutical Ingredient available in USP/IP/IH pharmacopoeia grades.
• Potassium Guaiacol Sulfonate An expectorant Active Pharmaceutical Ingredient available in BPC/USP/JP/FP pharmacopoeia grades.
• Chlorphenesin Carbamate A skeletal muscle relaxant Active Pharmaceutical Ingredient available in JP pharmacopoeia grade.
• Drotaverine Hydrochloride An anti-spasmodic Active Pharmaceutical Ingredient available in IH/IP pharmacopoeia grades.
• Mebeverine Hydrochloride An anti-spasmodic Active Pharmaceutical Ingredient available in BP/IP pharmacopoeia grades.
• Terazosin Hydrochloride An anti-hypertensive Active Pharmaceutical Ingredient available in USP/IP pharmacopoeia grades.
• Prazosin Hydrochloride An anti-hypertensive Active Pharmaceutical Ingredient available in USP/BP/EP/IP pharmacopoeia grades.
• Calcium Polycarbophil A gastrointestinal medication Active Pharmaceutical Ingredient (bulk-forming laxative) available in USP pharmacopoeia grade.
• Calcium Glycerophosphate A dietary supplement Active Pharmaceutical Ingredient (minerals and electrolytes) available in USP/EP/BP pharmacopoeia grades.
• Silica Thiol A metal scavenger pharmaceutical intermediate produced to in-house specifications.
• Manufacturing Services Contract manufacturing services for APIs and intermediates with advanced machinery and technologies across three integrated manufacturing facilities, handling varied process reactions and high reactor volumes for pharmaceutical manufacturers.

Quantifiable outcome

• 80% of non-hazardous waste recycled
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Divis Laboratories: Large Indian API and intermediates manufacturer headquartered in Hyderabad with deep USFDA/EU regulatory footprint across multiple therapeutic categories. Direct competitor in generic small-molecule API manufacturing serving global generic and innovator customers.
• Granules India: Hyderabad-headquartered manufacturer of APIs, pharmaceutical formulation intermediates (PFIs), and finished dosages with USFDA-approved facilities. Directly comparable in being an Indian API-focused manufacturer with diversified therapeutic portfolio and global customer base.
• Suven Pharma: Hyderabad-based CRAMS and API manufacturer with strong process-chemistry capability across niche molecules and global regulatory approvals (USFDA, EDMF). Comparable in therapeutic-niche positioning and contract development support for innovator pharma.
• Neuland Laboratories: Hyderabad-based API and intermediates manufacturer with similar scale (~1,000-1,500 employees) and USFDA/EU GMP approvals, serving global generic pharmaceutical companies. Closely comparable in product scope, regulatory posture, and customer segments.
• Hikal Ltd: Indian manufacturer of APIs, intermediates, and contract manufacturing services with multi-site manufacturing in Maharashtra and Karnataka. Comparable as a mid-sized Indian API/intermediate supplier with global regulatory approvals and pharma-customers.

Emerging players

• Sequent Scientific: Indian manufacturer focused on animal health APIs and formulations with selective human API exposure. Partial overlap in small-molecule API manufacturing capabilities and Indian manufacturing footprint, though different end-market focus.

Broad incumbents

• Piramal Pharma Solutions: Global CDMO with API manufacturing capabilities across small molecules and sterile injectables. Comparable as a contract API manufacturer with USFDA/EU approvals, though broader in scope (including biologics and ADCs).
• Aurobindo Pharma: Vertically integrated Indian pharmaceutical major with one of the largest generic API portfolios globally and broad regulatory footprint. Overlaps with Synthokem in supplying APIs for generic formulations but at materially larger scale across many more therapeutic categories.
• Laurus Labs: Indian-headquartered API and intermediates manufacturer with strong ARV and oncology API presence, plus formulation business. Overlaps with Synthokem in small-molecule API manufacturing with comparable Hyderabad ecosystem roots but larger product breadth.
• Jubilant Pharmova (Life Sciences): Indian pharmaceutical company with significant CDMO and API manufacturing businesses, including radiopharma and allergenic extracts. Comparable as a multi-facility, multi-jurisdictional API and intermediates supplier but operating at much larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/synthokem-labs-private-limited

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synthokem Labs